Effect of iron depletion in carbohydrate-intolerant patients with clinical evidence of nonalcoholic fatty liver disease

Facchini, Francesco S., Hua, Nancy W., Stoohs, Riccardo A.·2002·Gastroenterology
DOI 10.1053/gast.2002.32403

Cited by (233)

Items 201–233 of 233

  1. Iron, hepatitis C virus and hepatic steatosis
    J. A. Solís Herruzo, Pablo Solís‐Muñoz · 2004 · Revista Española de Enfermedades Digestivas
  2. Hepcidin and iron
    Chiara Vecchi, Antonello Pietrangelo · 2015 · Wiley eBooks
  3. A Crohn's disease patient who developed nonalcoholic steatosis and cirrhosis of the liver after surgical excision of the small intestines
    Yoriko Higuchi, Kazufumi Dohmen, Shunichiro Ayabe, Hirofumi Tanaka, Masatora Haruno, Shinji Shimoda · 2008 · Kanzo
  4. Hépatosidérose dysmétabolique : saigner ou ne pas saigner ?
    Fabrice Lainé, Yves Deugnier · 2008 · Gastroentérologie Clinique et Biologique
  5. Effect of intravenous iron on insulin sensitivity in dialysis patients
    Eduard A. Iliescu, Christine A. White, Edwin B. Toffelmire, ROBERT W. HUDSON · 2007 · Hemodialysis International
  6. Hfe-associated steatohepatitis: expression profiling and identifying the molecular basis of liver injury
    Nishreen Santrampurwala · 2016 · The University of Queensland
  7. Les surcharges hépatiques en fer chez l’homme
    Yves Deugnier · 2005 · Bulletin de l Académie Nationale de Médecine
  8. Neue Therapiemöglichkeiten bei nichtalkoholischer Fettleber
    Thomas Pusl, Burkhard Göke · 2007 · Der Diabetologe
  9. Hepatoprotectants Against Fatty Liver Disease: Antioxidants, Ursodeoxycholic Acid, and Herbal Medicines
    Anne-Catherine Bürgi, Jean‐François Dufour · 2013
  10. La enfermedad de hígado graso no alcohólica y su asociación con obesidad y estrés oxidativo hepático
    Rodrigo A Carrasco Loza, Rodrigo L Castillo Peñaloza, Patricio A Huerta Bustamante, Lilian Thielema · 2010 · Medunab
  11. Alteraciones hidrocarbonadas en los pacientes con infección crónica por el virus de la hepatitis C: estudio de prevalencia y de los mecanismos etiopatogénicos
    Albert Lecube · 2005 · Dipòsit Digital de Documents de la UAB (Universitat Autònoma de Barcelona)
  12. A case of chronic hepatitis C with sustained virologic response as well as improvement in insulin resistance after antiviral treatment
    Yoshio Sumida, Takako Wada, Naohisa Yoshida, Kyoko Sakai, Kazuyuki Kanemasa, Matahiro Yabuta · 2008 · Kanzo
  13. Round-table discussion on NASH and NAFLD in Japan: current status and future prospects
    Takeshi Okanoue, Toshiji Saibara, Shinji Tamura, Etsuko Hashimoto, Gotaro Yamada, Shunji Mishiro · 2006 · Kanzo
  14. Insulin resistance and iron overload
    James C. Barton, Corwin Q. Edwards, Pradyumna D. Phatak, Robert S. Britton, Bruce R. Bacon · 2010 · Cambridge University Press eBooks
  15. Investigation of the relationship between genetic and environmental risk factors associated with obesity and insulin resistance in South African patients with non-alcoholic fatty liver disease (NAFLD)
    Jakobus Pretorius · 2012 · SUNScholar (Stellenbosch University)
  16. Non-alcoholic steatohepatitis: metabolic syndrome of the liver
    Christopher Paul Day · 2008 · Springer eBooks
  17. Factores analíticos, antropométricos y dietéticos asociados al desarrollo de Esteatohepatitis y Fibrosis en pacientes con enfermedad por hígado graso no alcohólica
    Sara Gómez de la Cuesta · 2015
  18. Relationship of body iron stores with the development of nonalcoholic fatty liver disease
    Sang-Jun Hwang, Yong-Kyun Cho, Seyong Oh, Hyosun Choi, Jeong‐Sik Park, Shin-Yun Kim, Jung Ho Park, H. J. Kim, Dong Il Park, Chong-Il Sohn et al. · 2007 · The Korean Journal of Internal Medicine
  19. Liver MR imaging at 3T: challenges and opportunities
    Elizabeth M. Hecht, Bachir A. Taouli · 2011 · Cambridge University Press eBooks
  20. Iron Overload In Nonalcoholic Fatty Liver Disease
    Richard Kirsch, Ralph E. Kirsch · 2009 · CRC Press eBooks
  21. Non-alcoholic steatohepatitis — therapeutic interventions
    Chris Day · 2009 · Springer eBooks
  22. An Enormous Ventral (Epigastric) Hernia as a Cause of Acute Pancreatitis: Pfeffer's Closed Duodenal Loop Model in the Animal, First Seen in a Human
    Joo Young Kim, Kyung Hwan Kim, Min Goo Lee, Dong Min Shin, Shmuel Muallem, Frederick J. Suchy, Kim Kh · 2003
  23. Diagnostic, pronostic et possibilités thérapeutiques de la stéatose hépatique non alcoolique
    CM Oneta, Jean‐François Dufour · 2003 · Forum Médical Suisse ‒ Swiss Medical Forum
  24. Eisen (Fe)
    Cem Ekmekçioğlu · 2006 · Springer eBooks
  25. Hereditäre Lebererkrankungen
    Carolin Lackner, Alexander S. Knisely · 2020 · Pathologie
  26. Reply
    Francesco Facchini, Nancy W. Hua, Riccardo A. Stoohs · 2003 · Gastroenterology
  27. Correlation between Liver Fat Content and Iron Content in Patients with Non Alcoholic Fatty Liver Disease
    文妹 朱 · 2023 · Advances in Clinical Medicine
  28. The Effect of Sira Vedha (Phlebotomy) at Right Elbow Joint in the Management of Non-alcoholic Fatty Liver Disease - Randomized Controlled Clinical Trial
    Gaurav Rajendra Sawarkar, Priti Desai, Punam Gaurav Sawarkar · 2023 · Journal of Natural Remedies
  29. Estudio de las características fenotípicas y genotípicas en pacientes con hígado graso no alcohólico con sobrepeso vs.obesidad
    Beatriz Burgueño Gómez · 2023
  30. Effect of nurse-led phlebotomy on iron stores, insulin resistance, and blood lipids: a systematic review and meta-analysis
    Diego Mora‐Gonzalez, Alfonso Moreno‐Cabañas, Lucía Gonzalez García, Ana Isabel Cobo‐Cuenca, Maria del Carmen Muñoz‐Turrillas, Ricardo Mora‐Rodríguez, Felix Morales‐Palomo · 2026 · BMC Nursing
  31. Effect of Blood Donation in the Glycemic Control of Prediabetic Donors: A Blinded Randomized Controlled Trial
    Diego Mora‐Gonzalez, Alfonso Moreno‐Cabañas, Lucia Gonzalez-Garcia, Ana Isabel Cobo‐Cuenca, Maria del Carmen Muñoz‐Turrillas, Ricardo Mora‐Rodríguez, Felix Morales‐Palomo · 2026 · Endocrine Practice
  32. The Role of Cytochrome P450 Holoenzyme Metabolism in the Origin of Neuropathologies
    Snježana Štambuk · 2026 · International Journal of Molecular Sciences
  33. Elevated Uric Acid and Metabolic Dysfunction—Associated Steatotic Liver Disease Progression: Where There's Smoke, is There Fire?
    Eric E. Kelley, Owen M. Woodward, Nicholas K.H. Khoo · 2026 · Seminars in Liver Disease